These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7216515)

  • 1. Rat plasma lipoprotein inhibitors of lymphocyte proliferation: specific membrane receptor for very low density lipoproteins.
    Yi PI; Beck G; Zucker S
    Int Arch Allergy Appl Immunol; 1981; 65(1):8-14. PubMed ID: 7216515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane receptors for very low density lipoprotein (VLDL) inhibitor of lymphocyte proliferation.
    Yi PI; Beck G; Zucker S
    Blood; 1981 Jun; 57(6):1055-64. PubMed ID: 6261857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat hematopoietic cell receptors for very low density lipoprotein (VLDL) growth inhibitor.
    Zucker S; Beck G; Yi P; Lysik RM; DiStefano JF
    Exp Hematol; 1981 May; 9(5):550-62. PubMed ID: 7238661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very low density lipoprotein hematopoiesis inhibitor from rat plasma.
    Zucker S; Lysik RM; Chikkappa G; Glucksman MJ; Gomez-Reino J; DiStefano JF
    Exp Hematol; 1980 Aug; 8(7):895-905. PubMed ID: 16398021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.
    Morse JH; Witte LD; Goodman DS
    J Exp Med; 1977 Dec; 146(6):1791-803. PubMed ID: 200701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.
    Cuthbert JA; Lipsky PE
    J Clin Invest; 1984 Apr; 73(4):992-1003. PubMed ID: 6323541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoproteins can suppress accessory cell function and consequently suppress lymphocyte activation.
    Nakayasu T; Macy M; Okano Y; McCarthy BM; Harmony JA
    Exp Cell Res; 1986 Mar; 163(1):103-16. PubMed ID: 2935417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoproteins and transferrin regulate the proliferation of a continuous T lymphocyte cell line.
    McCarthy BM; Okano Y; Nakayasu T; Macy M; Watson SR; Harmony JA
    J Lipid Res; 1987 Sep; 28(9):1067-77. PubMed ID: 3498779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLDL modulates the cytokine secretion profile to a proinflammatory pattern.
    Sampedro MC; Motrán C; Gruppi A; Kivatinitz SC
    Biochem Biophys Res Commun; 2001 Jul; 285(2):393-9. PubMed ID: 11444855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of lymphocyte activation by plasma lipoproteins: modulation by cell number and type.
    Okano Y; Macy M; Cardin AD; Harmony JA
    Exp Cell Biol; 1985; 53(4):199-212. PubMed ID: 3875509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of in vitro lymphocyte response by streptozotocin-induced diabetic rat serum. A function of very-low-density lipoproteins.
    Chi DS; Berry DL; Dillon KA; Arbogast BW
    Diabetes; 1982 Dec; 31(12):1098-1104. PubMed ID: 6217099
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.
    Curtiss LK; Edgington TS
    J Clin Invest; 1978 May; 61(5):1298-308. PubMed ID: 207735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipemic-very low density lipoprotein, intermediate density lipoprotein and low density lipoprotein act synergistically with serotonin on vascular smooth muscle cell proliferation.
    Koba S; Pakala R; Katagiri T; Benedict CR
    Atherosclerosis; 2000 Mar; 149(1):61-7. PubMed ID: 10704615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ distribution of circulating very low density lipoproteins (VLDL): fate of hematopoietic growth inhibitory VLDL in the rat.
    Cornetta K; Zucker S
    Exp Hematol; 1983 Apr; 11(4):275-83. PubMed ID: 6840226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of lipoproteins in suppression of interleukin 2-dependent cell proliferation by sera from aged humans.
    Ohtsuka Y; Kobayashi K; Hirano T; Furukawa S; Nagano S; Takahashi T
    Gerontology; 1990; 36(5-6):268-75. PubMed ID: 2150198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory cells reduce lipoprotein suppression of lymphocyte activation.
    Okano Y; Macy M; Harmony JA
    Biochim Biophys Acta; 1985 Apr; 845(1):68-80. PubMed ID: 3872136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin on the disposal of 14C-labelled very low density lipoprotein triglycerides in intact and hepatectomized rats.
    Argilés J; Herrera E
    Diabetologia; 1983 Apr; 24(4):300-3. PubMed ID: 6345250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-related changes in the synthesis and secretion of very low density, low density and high density lipoproteins by cultured rat hepatocytes.
    Bell-Quint J; Forte T
    Biochim Biophys Acta; 1981 Jan; 663(1):83-98. PubMed ID: 7213773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. IX. Specific inhibition of DNA synthesis initiation by very low density lipoprotein and possible significance to the problem of liver regeneration.
    Leffert HL; Weinstein DB
    J Cell Biol; 1976 Jul; 70(1):20-32. PubMed ID: 180032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very low density and low density lipoproteins induce nitric oxide synthesis in macrophages.
    Mohan PF; Desaiah D
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1047-54. PubMed ID: 7980576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.